This inventor holds 1 USPTO granted patent and 3 EPO patents. Top assignee: Novo Nordisk A/s. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Lone Eskildsen: Innovator in Pharmaceutical Formulations
Introduction
Lone Eskildsen is a notable inventor based in Slangerup, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of insulin. His innovative work has the potential to improve the lives of many individuals requiring insulin therapy.
Latest Patents
Lone Eskildsen holds a patent for a pharmaceutical formulation comprising crystalline insulin and dissolved insulin. This invention provides a novel pharmaceutical formulation and a method for preparing it, which could enhance the effectiveness of insulin delivery.
Career Highlights
Lone Eskildsen is associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care. His work at Novo Nordisk has allowed him to focus on developing advanced solutions for insulin therapy, contributing to the company's mission of improving patient outcomes.
Collaborations
Lone has collaborated with notable colleagues, including Petter Lybeck (Berglund) and Charlotte Hammelev. Their teamwork has fostered an environment of innovation and excellence in pharmaceutical research.
Conclusion
Lone Eskildsen's contributions to pharmaceutical formulations, particularly in insulin therapy, highlight his role as an important inventor in the field. His work continues to pave the way for advancements in diabetes care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile